Acasti Pharma (ACST) Reports Q1 Loss of $0.18

Acasti Pharma (NASDAQ: ACST) reported Q1 EPS of ($0.18), versus ($0.21) reported last year. Revenue for the quarter came in at $21 thousand, versus $178 thousand reported last year.

For earnings history and earnings-related data on Acasti Pharma (ACST) click here.

You May Also Be Interested In

• Barrick Mining said to delay IPO of American gold business to 2027
• Snowflake soars 20% on earnings beat and raised guidance
• Broadcom shares fall 3% after revenue forecast misses estimates